Is Rivaroxaban included in medical insurance?

Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It can also be used as thromboprophylaxis in certain circumstances. It is also the first orally active direct Factor Xa inhibitor. Unlike warfarin, routine laboratory monitoring of INR is not necessary. However, there is no antidote available in the case of massive bleeding. Regardless of food, only take 10 mg tablets. The 15 mg and 20 mg tablets should be taken with food.

Rivaroxaban competitively inhibits free and coagulation-bound factor XaFactor Xa, which is required for the activation of prothrombin (factor II) to thrombin (factor IIa). Thrombin is a serine protease required to activate fibrinogen into fibrin, the loose network that completes the coagulation process. Since one factor Xa molecule can generate more than 1000 thrombin molecules, selective inhibitors of factor Xa are very useful in terminating the amplification of thrombin generation. The effects of rivaroxaban are irreversible.

RivaroxabanThe original drug is already on the market in China and can be found under Class B medical insurance. SpecificationsThe price of 10mg*5 tablets is around RMB 100. This drug may be sold in domestic pharmacies or hospitals. The Turkish version of rivaroxabanoriginal drug marketed overseas, specifications10mg*10 tablets, is priced around RMB 170 (the price may fluctuate due to exchange rates). The ingredients of the original rivaroxaban drug sold domestically and abroad are basically the same. Currently, there are no generic drugs produced in other countries on the market overseas.